# Intranasal Neurostimulation for the Treatment of Neurosensory Abnormalities in CL Wearers (INTAC)

> **NCT04240587** · NA · WITHDRAWN · sponsor: **Tufts Medical Center**

## Conditions studied

- Contact Allergy
- Neuropathic Pain

## Interventions

- **DEVICE:** TrueTear™ intranasal neurostimulator (ITN)

## Key facts

- **NCT ID:** NCT04240587
- **Lead sponsor:** Tufts Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-03-23
- **Primary completion:** 2021-11-03
- **Final completion:** 2021-11-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Difficulty in enrollment of study participants
- **Last updated:** 2021-11-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04240587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04240587, "Intranasal Neurostimulation for the Treatment of Neurosensory Abnormalities in CL Wearers (INTAC)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04240587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*